| Dr Starla K Goldman, DDS | |
|
13740 N Meridian, Carmel, IN 46032 | |
| (317) 582-0571 | |
| (317) 582-0671 |
| Full Name | Dr Starla K Goldman |
|---|---|
| Gender | Female |
| Speciality | Dentist |
| Location | 13740 N Meridian, Carmel, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073616876 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | 12009352 (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Starla K Goldman, DDS 13740 N Meridian, Carmel, IN 46032 Ph: (317) 582-0571 | Dr Starla K Goldman, DDS 13740 N Meridian, Carmel, IN 46032 Ph: (317) 582-0571 |
News Archive
Diabetes is caused by damaged or non-existing insulin cells inability to produce insulin, a hormone that is necessary in regulating blood sugar levels. Many diabetes patients take insulin supplements to regulate these levels.
The "Blueprint for an AIDS-free Generation," released on Thursday by U.S. Secretary of State Hillary Clinton, "shows that upfront investments to support the rapid scale-up of lifesaving AIDS treatment will yield significant savings - of both lives and dollars - in the near future," Archbishop Desmond Tutu, archbishop emeritus of Cape Town, South Africa, writes in the Huffington Post's "Impact" blog.
Habitual coffee drinking is not associated with an increased risk of hypertension in women, although an association was found with the consumption of sugared or diet colas, according to a study in the November 9 issue of JAMA: The Journal of the American Medical Association.
Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics, today announced the initiation of a Phase 2b clinical study of TC-5214 as a treatment for overactive bladder.
Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced that it has engaged the Numoda Corporation, a leading information, process and logistics management company, to oversee the Phase III clinical trial of DAVANAT and 5-FU compared with the standard of care in the treatment of patients with advanced, metastatic colorectal cancer.
› Verified 6 days ago
Dr. Ronald L Miller, MSD, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 715 W Carmel Dr, Ste 201, Carmel, IN 46032 Phone: 317-844-6284 Fax: 317-580-9495 | |
Elizabeth B. Lewis, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 12720 Meeting House Rd, Carmel, IN 46032 Phone: 317-571-1900 Fax: 317-569-9695 | |
Dr. O H Rigsbee Iii, DDS Dentist Medicare: Medicare Enrolled Practice Location: 13590 B North Meridian St., Suite 204, Carmel, IN 46032 Phone: 317-574-0612 Fax: 317-564-0614 | |
Nancy Z Halsema, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 3965 W 106th St, Suite 100, Carmel, IN 46032 Phone: 317-253-8631 Fax: 317-876-9715 | |
Nadia Samini, Dentist Medicare: Not Enrolled in Medicare Practice Location: 1040 N Rangeline Rd Ste B, Carmel, IN 46032 Phone: 317-846-3436 | |
Fidel Barbosa, D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 12525 N Meridian St, Carmel, IN 46032 Phone: 317-571-9610 Fax: 317-571-9620 | |
Jack M Miller, DDS Dentist Medicare: Medicare Enrolled Practice Location: 12720 Meeting House Rd, Carmel, IN 46032 Phone: 317-571-1900 Fax: 317-569-9695 |